Enzymatic modification of low-density lipoprotein in the arterial wall: a new role for plasmin and matrix metalloproteinases in atherogenesis

Arteriosclerosis, Thrombosis, and Vascular Biology
M TorzewskiKarl J Lackner

Abstract

Functionally interactive proteases of the plasminogen/plasmin and the matrix metalloproteinase (MMP) system degrade and reorganize the extracellular matrix of the vessel wall in atherosclerosis. Here we investigated whether such proteases are able to confer atherogenic properties onto low density lipoprotein by nonoxidative modification. Similar to the recently described enzymatically-modified low-density lipoprotein (E-LDL), native LDL exposed to plasmin or matrix MMP-2 or MMP-9 and cholesterylester-hydrolase (CEH) showed extensive deesterification, with ratios of free cholesterol to total cholesterol rising to 0.8 compared with 0.2 in native LDL. When the ratio exceeded 0.6, both plasmin/CEH-LDL and MMP/CEH-LDL fused into larger particles. In parallel, they gained C-reactive protein-dependent complement-activating capacity. E-LDL produced with any protease/CEH combination was efficiently taken up by human macrophages, whereby marked induction of MMP-2 expression by E-LDL was observed. These in vitro findings had their in vivo correlates: urokinase-type plasminogen activator, MMP-2, and MMP-9 were detectable in both early and advanced human atherosclerotic lesions in colocalization with E-LDL. Plasmin and MMP-2/MMP-9 may not o...Continue Reading

References

Feb 23, 1976·Biochimica Et Biophysica Acta·T SakuradaM Murakami
Nov 16, 1984·Journal of Immunological Methods·S BhakdiW Nürnberger
Nov 13, 1998·Current Opinion in Lipidology·K J Williams, I Tabas
Jan 27, 1999·Annals of Medicine·S Bhakdi
Dec 20, 2002·Nature·Peter Libby
Mar 5, 2003·Arteriosclerosis, Thrombosis, and Vascular Biology·Shan-Rui HanMatthias Husmann
Mar 27, 2004·Thrombosis and Haemostasis·Sucharit BhakdiMatthias Husmann

❮ Previous
Next ❯

Citations

Dec 18, 2008·Lipids·Borros Arneth
Oct 30, 2008·Proceedings of the National Academy of Sciences of the United States of America·Michal KremenDavid A Dichek
Sep 9, 2006·Current Opinion in Lipidology·Katariina Oörni, Petri T Kovanen
Sep 16, 2006·Biological Chemistry·Martin LinkeDieter Brömme
Dec 14, 2006·Clinical Chemistry and Laboratory Medicine : CCLM·Michael Torzewski, Karl J Lackner
Oct 19, 2006·Acta histochemica·Luigi Fabrizio RodellaRossella Bianchi
Nov 22, 2016·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Fei ChengMichael Torzewski
May 27, 2017·Journal of Clinical Periodontology·Matthias MunzArne S Schäefer
Jul 26, 2016·Frontiers in Physiology·Kamel BoukaisJean-Baptiste Michel
Sep 11, 2018·Periodontology 2000·Arne S Schaefer
Nov 11, 2020·International Journal of Molecular Sciences·Takashi Obama, Hiroyuki Itabe
Sep 27, 2012·Clinical Biochemistry·Michael Torzewski, Sucharit Bhakdi
May 1, 2021·Journal of Clinical Medicine·Katariina Öörni, Petri T Kovanen
May 23, 2006·Atherosclerosis·Anne LeclercqJean-Baptiste Michel
Aug 30, 2006·Molecular Immunology·Adrienn BiróGérard J Arlaud
Aug 21, 2008·Archives of Biochemistry and Biophysics·Ryan T HamiltonTzung K Hsiai
Jun 24, 2009·Clinica Chimica Acta; International Journal of Clinical Chemistry·Sanjay K SinghAlok Agrawal

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.